NEWS COVERAGE

INVESTOR UPDATE

PRESS RELEASE

Healthcare works best when it’s simple, affordable, and reliable.

INVESTOR UPDATE

Morepen Laboratories Limited India’s Post

INVESTOR UPDATE

FM Sitharaman proposes ₹10,000 crore investment in biopharma

NEWS COVERAGE

Budget 2026 healthcare and biopharma focus shapes outlook for Morepen, Mankind Pharma, BSV, Park Hospitals, HCG Cancer Centre, MediJourn, Ramky Infrastructure, Anondita Medicare, JK Lakshmi Cement and others

NEWS COVERAGE

Dividend ANNOUNCED after 2001; Rs 60 stock price – Pharma company Q4 results

NEWS COVERAGE

Board of Morepen Laboratories recommends Final Dividend

NEWS COVERAGE

PRESS RELEASE

Empowering the Unsung: 'Thank You' Multivitamins for Domestic Heroes

NEWS COVERAGE

“Thank You” House Help “Thank You” Dr. Morepen ₹499 for a 1-year Multivitamin Pack

NEWS COVERAGE

“Thank You” House Help: “Thank You” Dr. Morepen ₹499 for a 1-year Multivitamin Pack

NEWS COVERAGE

PRESS RELEASE

Morepen Labs receives CDSCO nod to conduct studies on fatty liver drug

NEWS COVERAGE

Morepen receives CDSCO nod to conduct BE studies for Resmetirom

NEWS COVERAGE

Morepen receives CDSCO nod to conduct BE studies for Resmetirom

NEWS COVERAGE

Morepen Laboratories plans to add 1,000 medical representatives

PRESS RELEASE

PRESS RELEASE

PRESS RELEASE

Morepen Labs shares rise on China export approval for allergy drug

NEWS COVERAGE

Morepen Laboratories secures approval for Loratadine API in China

NEWS COVERAGE

Morepen Laboratories receives China NMPA approval for Loratadine

NEWS COVERAGE

Morepen Laboratories shares rise 2% after China approves Loratadine API

NEWS COVERAGE

Morepen Laboratories secures CDE China approval for Loratadine API, expanding global reach

NEWS COVERAGE

PRESS RELEASE

Morepen launches Empamore for diabetes care with affordable treatment

PRESS RELEASE

Morepen Laboratories zooms on launching Empamore

NEWS COVERAGE

Morepen Laboratories expands diabetes treatment access with affordable Empamore launch

NEWS COVERAGE

Morepen Launches Empamore for Diabetes, Heart & Kidney Care

NEWS COVERAGE

MOREPEN LABS Gains 11%; BSE HEALTHCARE Index Up 1.4%

NEWS COVERAGE

Morepen Labs shares skyrocket 12% on rolling out 'Empamore'

NEWS COVERAGE

Morepen Labs launches new cost-effective drug for diabetes, heart failure and kidney disease

NEWS COVERAGE

Morepen Laboratories shares zoom 10% as company launches Empamore, 'a game-changing treatment' for Type 2 Diabetes; check details

NEWS COVERAGE

Morepen Lab soars on launching Empamore to combat diabetes in India

NEWS COVERAGE

Morepen Laboratories' sugar-busting bargain hits Indian market

NEWS COVERAGE

Morepen Labs launches diabetes drug Empamore

NEWS COVERAGE

Morepen Lab Issues Big Update On New Drug For Type 2 Diabetes, Shares Likely To React

NEWS COVERAGE

PRESS RELEASE

PRESS RELEASE

Dr Morepen Eyes Rs 500-Crore Revenue From Wellness Business In Four Years

NEWS COVERAGE

लाइटलाइफ़ के साथ डॉ. मोरपेन ने रखा वेलनेस सेगमेंट में कदम

NEWS COVERAGE

Dr Morepan ने लॉन्च किए वैलनेस प्रोडक्ट, 12,000 करोड़ के वेट मैनेजमेंट बाजार में दस्तक

NEWS COVERAGE

भारत में मोटापा बढ़ा रहा खतरा, डॉ. मोरपेन का 'लाइटलाइफ' बन सकता है गेमचेंजर! जानिए कैसे करेगा काम

NEWS COVERAGE

Dr Morepen forays into wellness segment with weight management initiative

NEWS COVERAGE

Dr. Morepen enters wellness segment with weight management solution, focuses on India market

NEWS COVERAGE

PRESS RELEASE

Dr Morepan ने वैलनेस प्रोडक्ट लॉन्च किए, इनके जरिए घटा सकते हैं अपना वजन

NEWS COVERAGE

Dr Morepen Tackles Obesity with New Wellness Initiative

NEWS COVERAGE

LIGHTLIFE LAUNCH MARKS DR MOREPEN’S FORAY INTO WELLNESS SEGMENT

NEWS COVERAGE

Dr Morepen forays into wellness segment with weight management initiative

NEWS COVERAGE

Dr Morepen forays into wellness segment with weight management initiative

NEWS COVERAGE

Maximum Doctors Pledge to Help Indians Enjoy the Freedom of Good Gut Health

NEWS COVERAGE

PRESS RELEASE

Morepen Lab Standalone September 2024 Net Sales at Rs 383.70 crore, up 0.64% Y-o-Y

NEWS COVERAGE

Morepen Labs Q2 Net Profit Jumps Over 6-fold To Rs 27 Cr

NEWS COVERAGE

Morepen Laboratories consolidated net profit rises 63.92% in the September 2024 quarter

NEWS COVERAGE

PRESS RELEASE

The speed of innovation is both a challenge and an opportunity

NEWS COVERAGE

NEWS COVERAGE

Dr. Morepen’s diabetes awareness campaign kicks on KBC

NEWS COVERAGE

PRESS RELEASE

Morepen Laboratories Reaches New Heights Market Cap Surpasses Rs. 5000 Crore

NEWS COVERAGE

Morepen Laboratories: Smallcap Pharma Company Shines with Record High Stock Performance

NEWS COVERAGE

Morepen Laboratories' Stock Reaches 52-Week High, Outperforms Sector and Sensex

NEWS COVERAGE

Morepen Laboratories Reaches New Heights: Market Cap Surpasses Rs. 5000 Crore

NEWS COVERAGE

Morepen Labs shares hit fresh one-year high as stock rallies 56% in a month; here's why

NEWS COVERAGE

The stock hit a multi-year high of Rs 88.85 was trading 63 per cent higher against its qualified institutional placement (QIP) price of Rs 54.37 per share.

NEWS COVERAGE

Why Morepen Laboratories Share Price is Rising

NEWS COVERAGE

Dr. Morepen: Your Partner in Health with Omega-3

INVESTOR UPDATE

Morepen Labs stock hits 52-week high logging 15% intraday rally. More steam left?

NEWS COVERAGE

Here's why Mayuresh Joshi is bullish on Morepen Labs

NEWS COVERAGE

Morepen Labs launches Rs 250 crore QIP with greenshoe option

NEWS COVERAGE

Morepen Labs Q1 FY25 Profit Surges by 147%, Revenue Grows by 14% Morepen Labs successfully raised Rs. 200 Crore through QIP

NEWS COVERAGE

Breakout stocks to buy: Matrimony to Morepen Lab

NEWS COVERAGE

Financial results Q1-2024-25

NEWS COVERAGE

PRESS RELEASE

INVESTOR UPDATE

PRESS RELEASE

Here's why Mayuresh Joshi is bullish on Morepen Labs

NEWS COVERAGE

Morepen Labs successfully raises Rs.200 crore through QIP

NEWS COVERAGE

PRESS RELEASE

Morepen Labs launches Rs 250 crore QIP with greenshoe option

NEWS COVERAGE

Morepen Laboratories launches QIP to raise up to ₹200 crore

NEWS COVERAGE

Morepen Laboratories consolidated net profit rises 243.20% in the March 2024 quarter

NEWS COVERAGE

Morepen Labs Profit surges 143 percent while Revenue grows 20 percent in FY24, Dr. Morepen Medical Devices sales soar by 35 percent

NEWS COVERAGE

Dr. Morepen’s Revolutionary Intelicaps® Technology for Enhanced Probiotic Delivery, First time in India

NEWS COVERAGE

Gut Reaching Probiotics – Revolutionary, Intebact

NEWS COVERAGE

Pharma stock under ₹ 50 jumps 9% after company announces net profit increase of 249% in Q4

NEWS COVERAGE

Morepen Laboratories consolidated net profit rises 243.20% in the March 2024 quarter

NEWS COVERAGE

Morepen Lab Standalone March 2024 Net Sales at Rs 392.60 crore, up 16.66% Y-o-Y

NEWS COVERAGE

PRESS RELEASE

Burnol . Lifespring and now lemolate ; Dr. Morepen Brand Basket grows

NEWS COVERAGE

Morepen Laboratories : Dr. Morepen Partners with OptiBiotix to Deliver Safe, ScienceBacked Weight Management Solution to India

PRESS RELEASE

PRESS RELEASE

Morepen Laboratories Limited’ Q3 FY24 EBITDA Surges By 151 Per Cent, Net Profit Records A Remarkable 256 Per Growth

PRESS RELEASE

PRESS RELEASE

Morepen - The Future of Home Diagnostics and OTC Health Products

PRESS RELEASE

PRESS RELEASE

Mr. Sushil Suri, Chairman & MD of Morepen Laboratories Ltd. honored to be the chief guest of the Annual Graduation & Convocation Ceremony of Chandigarh University.

PRESS RELEASE

PRESS RELEASE

PRESS RELEASE

Morepen Laboratories : gets USFDA Approval for Fexofinadine (Allegra) Expected to start export in Q4'FY22

PRESS RELEASE

PRESS RELEASE

INVESTOR UPDATE

Sushil Suri Of Morepen Lab Speaks On Q1 Performance And Growth Ahead | Halftime Report | CNBC-TV18

NEWS COVERAGE

Morepen Labs Q1 net profit rises 57% at Rs. 30.47 crore

NEWS COVERAGE

Morepen Laboratories Q1 profit jumps 57 pc to Rs 30.47 cr

NEWS COVERAGE

Morepen clocks 57 pc growth in Q1 PAT at Rs 30 crore

NEWS COVERAGE

मोरपेन लेबोरेटरीज का मुनाफा पहली तिमाही में 57 फीसदी बढ़ा

NEWS COVERAGE

Morepen Laboratories Q1 profit jumps 57% to Rs 30.47 cr

NEWS COVERAGE

Morepen Labs' net revenue up 50 per cent to Rs 388.31 Cr in Q1 FY’22

NEWS COVERAGE

Morepen records highest ever quarterly revenue Rs388.31cr in Q1FY22, growth of 50% yoy; Stock ends higher

NEWS COVERAGE

Morepen Laboratories Q1FY22: Profit jumps 57% to Rs 30.47 cr

NEWS COVERAGE

Morepen clocks 57 pc growth in Q1 PAT at Rs 30 crore

NEWS COVERAGE

Morepen clocks 57 pc growth in Q1 PAT at Rs 30 crore

NEWS COVERAGE

Morepen Lab gains after Q1 PAT rises 57% YoY

NEWS COVERAGE

Morepen Laboratories Q1 results: Net profit jumps 57% to Rs 30 cr

NEWS COVERAGE

Morepen Lab Consolidated June 2021 Net Sales at Rs 386.73 crore, up 50.1% Y-o-Y

NEWS COVERAGE

Plan is to make key intermediates for production and reduce dependence on China, says Morepen Lab

NEWS COVERAGE

NEWS COVERAGE

NEWS COVERAGE

NEWS COVERAGE

Morepen Laboratories profit jumps 57%

NEWS COVERAGE

NEWS COVERAGE

PRESS RELEASE

Morepen Quarterly Results Coverage on CNBC Awaaz

NEWS COVERAGE

CMD, Sushil Suri's Interview on CNBC Bazaar

NEWS COVERAGE

PRESS RELEASE

NEWS COVERAGE

NEWS COVERAGE

NEWS COVERAGE

NEWS COVERAGE

NEWS COVERAGE

CNBC TV18 Interview about $100M Fund Raise by Morepen

NEWS COVERAGE

INVESTOR ANNOUNCEMENTS

PRESS RELEASE

PRESS RELEASE

PRESS RELEASE

PRESS RELEASE

PRESS RELEASE

PRESS RELEASE

PRESS RELEASE